Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-12 · accession 0001127602-24-018708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-12 | BCRX | ASELAGE STEVE | Dir | A - Grant | $0.00 | +6,820 | 70.2K | +11% | $0 |
| D | 2024-06-14 | 2024-06-12 | BCRX | ASELAGE STEVE | Dir | A - Grant | $0.00 | +49.9K | 49.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-12 | A | A | 6,820 | $0.00 | 70,159 | D | — | — | (F1) Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. |
| 2 | Derivative | Automatic Stock Option Grant | 2024-06-12 | A | A | 49,933 | $0.00 | 49,933 | D | $6.30 · 2025-06-12 to 2034-06-12 | 49,933 Common Stock | (F2) Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. |